These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32408680)

  • 1. The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models.
    Bécot A; Pardossi-Piquard R; Bourgeois A; Duplan E; Xiao Q; Diwan A; Lee JM; Lauritzen I; Checler F
    Cells; 2020 May; 9(5):. PubMed ID: 32408680
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology.
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Pagnotta S; Biferi MG; Barkats M; Lacor P; Klein W; Bauer C; Checler F
    Acta Neuropathol; 2016 Aug; 132(2):257-276. PubMed ID: 27138984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway.
    Zhang YD; Zhao JJ
    DNA Cell Biol; 2015 Nov; 34(11):661-8. PubMed ID: 26368054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons.
    Yamamoto F; Taniguchi K; Mamada N; Tamaoka A; Kametani F; Lakshmana MK; Araki W
    Neuroscience; 2019 Mar; 402():11-22. PubMed ID: 30677488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
    Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
    Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
    Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
    Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
    J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer's disease models.
    Guan XJ; Deng ZQ; Liu J; Su CF; Tong BC; Zhu Z; Sreenivasmurthy SG; Kan YX; Lu KJ; Chu CP; Pi RB; Cheung KH; Iyaswamy A; Song JX; Li M
    Acta Pharmacol Sin; 2024 May; 45(5):900-913. PubMed ID: 38225393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.
    Meng X; Luo Y; Liang T; Wang M; Zhao J; Sun G; Sun X
    J Alzheimers Dis; 2016 Apr; 52(3):1135-50. PubMed ID: 27060963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).
    Zheng X; Lin W; Jiang Y; Lu K; Wei W; Huo Q; Cui S; Yang X; Li M; Xu N; Tang C; Song JX
    Autophagy; 2021 Nov; 17(11):3833-3847. PubMed ID: 33622188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells.
    Bustamante HA; Rivera-Dictter A; Cavieres VA; Muñoz VC; González A; Lin Y; Mardones GA; Burgos PV
    PLoS One; 2013; 8(12):e83096. PubMed ID: 24376644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.
    Tan X; Guan H; Yang Y; Luo S; Hou L; Chen H; Li J
    Toxicol Appl Pharmacol; 2020 Aug; 401():115090. PubMed ID: 32512069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease?
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Bécot A; Checler F
    Curr Alzheimer Res; 2019; 16(5):453-457. PubMed ID: 30907322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.
    Lauritzen I; Pardossi-Piquard R; Bauer C; Brigham E; Abraham JD; Ranaldi S; Fraser P; St-George-Hyslop P; Le Thuc O; Espin V; Chami L; Dunys J; Checler F
    J Neurosci; 2012 Nov; 32(46):16243-1655a. PubMed ID: 23152608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.